Skip to main content
Helmholtz Munich logoHelmholtz Munich logoHelmholtz Munich logoHelmholtz Munich logoHelmholtz Munich logo
Abstract illustration of targeting cancer cell made of glowing neon particles. Blue geometric background depicting cancer cell screening and disease treatment medical concept
AI, Computational Health, ICB,

Cancer Plasticity Atlas To Improve Cancer Therapies

Helmholtz Munich, the Wellcome Sanger Institute, and Parse Biosciences have announced a collaboration to develop a single cell atlas focused on cancer plasticity and its response to therapies. This initiative will lay the foundation for a larger…

weiterlesen

Human/Mouse/Rat Proteine

Verhandlungsverfahren ohne TW

weiterlesen
Arctic-Funk-Lehmann-DFG
Environmental Health, LHI,

New Research Project ARCTIC Explores How Aging Disrupts Lung Cell Communication

LHI scientists Mareike Lehmann and Maja Funk receive DFG grant to investigate age-related epithelial-immune cell interactions in the lung

 

weiterlesen
Diabetes, IDM,

Copenhagen Declaration: A New Start in Diabetes Prevention

The Copenhagen Declaration developed by the Global Diabetes Forum outlines a new vision for combating the global type 2 diabetes epidemic. More than 50 experts from industrialized and emerging countries are calling for far-reaching changes in…

weiterlesen
Doctor talking with a diabetes patient
Gene-editing scissors cut a DNA strand
Transfer,

License Agreement to Expand its CRISPR/Cas9 Gene Editing Services

Taconic Biosciences, a global leader in providing animal model solutions and services, entered into an exclusive license agreement with Helmholtz Munich to provide preclinical researchers with advanced CRISPR gene editing services. Through this…

weiterlesen

AbsoluteIDQ p180 kit (96), AbsoluteIDQ Bile Acids kit

Verhandlungsverfahren ohne TW

 

weiterlesen